Research
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
Steven T. Bird, Abraham G. Hartzema, James M. Brophy, Mahyar Etminan and Joseph A.C. Delaney
CMAJ February 05, 2013 185 (2) E115-E120; DOI: https://doi.org/10.1503/cmaj.120677
Steven T. Bird
Department of Health and Human Services (Bird), Food and Drug Administration, Center for Drug Evaluation and Research, Office of Management and Academic Collaboration Program; Department of Pharmaceutical Outcome and Policy (Bird, Delaney, Hartzema), University of Florida College of Pharmacy, Gainesville, Fla.; Department of Medicine and Epidemiology (Brophy), McGill University, Montréal, Que.; and the Pharmaceutical Outcomes Programme (Etminan), School of Medicine, University of British Columbia, Vancouver, BC
PharmD MSAbraham G. Hartzema
Department of Health and Human Services (Bird), Food and Drug Administration, Center for Drug Evaluation and Research, Office of Management and Academic Collaboration Program; Department of Pharmaceutical Outcome and Policy (Bird, Delaney, Hartzema), University of Florida College of Pharmacy, Gainesville, Fla.; Department of Medicine and Epidemiology (Brophy), McGill University, Montréal, Que.; and the Pharmaceutical Outcomes Programme (Etminan), School of Medicine, University of British Columbia, Vancouver, BC
PhD PharmDJames M. Brophy
Department of Health and Human Services (Bird), Food and Drug Administration, Center for Drug Evaluation and Research, Office of Management and Academic Collaboration Program; Department of Pharmaceutical Outcome and Policy (Bird, Delaney, Hartzema), University of Florida College of Pharmacy, Gainesville, Fla.; Department of Medicine and Epidemiology (Brophy), McGill University, Montréal, Que.; and the Pharmaceutical Outcomes Programme (Etminan), School of Medicine, University of British Columbia, Vancouver, BC
PhD MDMahyar Etminan
Department of Health and Human Services (Bird), Food and Drug Administration, Center for Drug Evaluation and Research, Office of Management and Academic Collaboration Program; Department of Pharmaceutical Outcome and Policy (Bird, Delaney, Hartzema), University of Florida College of Pharmacy, Gainesville, Fla.; Department of Medicine and Epidemiology (Brophy), McGill University, Montréal, Que.; and the Pharmaceutical Outcomes Programme (Etminan), School of Medicine, University of British Columbia, Vancouver, BC
PharmD MSJoseph A.C. Delaney
Department of Health and Human Services (Bird), Food and Drug Administration, Center for Drug Evaluation and Research, Office of Management and Academic Collaboration Program; Department of Pharmaceutical Outcome and Policy (Bird, Delaney, Hartzema), University of Florida College of Pharmacy, Gainesville, Fla.; Department of Medicine and Epidemiology (Brophy), McGill University, Montréal, Que.; and the Pharmaceutical Outcomes Programme (Etminan), School of Medicine, University of British Columbia, Vancouver, BC
PhDData supplements
Online Appendices
Related Articles
- (2013). Highlights. CMAJ, 185(2), 105. Accessed August 17, 2024. Retrieved from http://www.cmaj.ca/content/185/2/105.
In this issue
Article tools
Respond to this article
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
Steven T. Bird, Abraham G. Hartzema, James M. Brophy, Mahyar Etminan, Joseph A.C. Delaney
CMAJ Feb 2013, 185 (2) E115-E120; DOI: 10.1503/cmaj.120677
Jump to section
Related Articles
Cited By...
- Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential
- Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
- Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databases
- Risk of acute kidney injury associated with the use of fluoroquinolones